{
  "issuer_name": "Extendicare Inc.",
  "reporting_date": "2023-09-30",
  "reporting_period": "Q3 2023 (Nine months ended September 30, 2023)",
  "currency": "CAD",
  "data_quality": {
    "completeness": "moderate",
    "source": "Q3 2023 Consolidated Financial Statements and MD&A",
    "validation_notes": "Extendicare is a healthcare services company with significant real estate ownership. Reports FFO/AFFO but NOT a traditional REIT. Limited portfolio metrics available as properties are owner-occupied (LTC homes) not investment properties. No GLA data. ACFO not reported by issuer - would need to be calculated in Phase 3."
  },
  "balance_sheet": {
    "reporting_date": "2023-09-30",
    "total_assets": 687994,
    "investment_properties": 0,
    "investment_properties_held_for_sale": 0,
    "equity_accounted_investments": 25629,
    "cash": 96252,
    "total_liabilities": 592365,
    "mortgages_noncurrent": 318708,
    "mortgages_current": 20567,
    "credit_facilities": 0,
    "senior_unsecured_debentures": 126500,
    "total_unitholders_equity": 95629,
    "common_units_outstanding": 85218,
    "diluted_units_outstanding": 96106
  },
  "dilution_detail": {
    "basic_units": 85218,
    "dilutive_instruments": {
      "restricted_units": 0,
      "deferred_units": 0,
      "stock_options": 0,
      "convertible_debentures": 10888,
      "warrants": 0,
      "other": 0
    },
    "diluted_units_calculated": 96106,
    "diluted_units_reported": 96106,
    "dilution_percentage": 12.78,
    "reconciliation_note": "Dilution entirely from convertible debentures. Calculated: 96,106 - 85,218 = 10,888 units. Dilution %: (96,106 - 85,218) / 85,218 * 100 = 12.78%",
    "disclosure_source": "Q3 2023 MD&A page 20, Table 25 - Weighted average shares basic and diluted"
  },
  "income_statement": {
    "noi": 108244,
    "interest_expense": 11064,
    "revenue": 954776,
    "net_income": 25362,
    "nine_months_2023": {
      "revenue": 954776,
      "operating_expenses": 846532,
      "noi": 108244,
      "administrative_costs": 41720,
      "depreciation_amortization": 23547,
      "interest_expense": 11064,
      "net_income": 25362
    },
    "q3_2023": {
      "revenue": 322529,
      "operating_expenses": 287319,
      "noi": 35210,
      "administrative_costs": 14440,
      "depreciation_amortization": 9023,
      "interest_expense": 3725,
      "net_income": 11831
    }
  },
  "ffo_affo": {
    "ffo": 37575,
    "affo": 42166,
    "ffo_per_unit": 0.44,
    "ffo_per_unit_diluted": 0.44,
    "affo_per_unit": 0.49,
    "affo_per_unit_diluted": 0.47,
    "acfo": 0,
    "acfo_per_unit": 0,
    "distributions_per_unit": 0.36,
    "nine_months_2023": {
      "ffo": 37575,
      "affo": 42166,
      "ffo_per_unit": 0.44,
      "affo_per_unit": 0.49,
      "distributions_declared": 30404,
      "distributions_per_unit": 0.36
    },
    "q3_2023": {
      "ffo": 11412,
      "affo": 12290,
      "ffo_per_unit": 0.13,
      "affo_per_unit": 0.14,
      "distributions_declared": 10122,
      "distributions_per_unit": 0.12
    }
  },
  "portfolio": {
    "total_properties": 0,
    "total_gla_sf": 0,
    "occupancy_rate": 0,
    "occupancy_with_commitments": 0,
    "same_property_noi_growth_6m": 0,
    "note": "Extendicare operates long-term care homes (owner-occupied, not investment properties). Portfolio metrics (property count, GLA, occupancy) not disclosed in same manner as REITs. Company operates 56 managed LTC homes via joint venture and owns equity interest in joint ventures."
  },
  "ffo_affo_components": {
    "net_income_ifrs": 25362,
    "unrealized_fv_changes": 0,
    "depreciation_real_estate": 23547,
    "amortization_tenant_allowances": 0,
    "amortization_intangibles": 0,
    "gains_losses_property_sales": 8720,
    "tax_on_disposals": 0,
    "deferred_taxes": -1790,
    "impairment_losses_reversals": 0,
    "revaluation_gains_losses": 0,
    "transaction_costs_business_comb": 0,
    "foreign_exchange_gains_losses": 0,
    "sale_foreign_operations": 0,
    "fv_changes_hedges": 972,
    "goodwill_impairment": 0,
    "puttable_instruments_effects": 0,
    "discontinued_operations": 0,
    "equity_accounted_adjustments": 0,
    "incremental_leasing_costs": 0,
    "property_taxes_ifric21": 0,
    "rou_asset_revenue_expense": 0,
    "non_controlling_interests_ffo": 0,
    "capex_sustaining": 7945,
    "capex_development": 0,
    "leasing_costs": 0,
    "tenant_improvements": 0,
    "straight_line_rent": 0,
    "non_controlling_interests_affo": 0,
    "other_adjustments": [
      {
        "label": "other_1",
        "description": "Depreciation for FFEC (furniture, fixtures, equipment, computers) - maintenance capex deduction",
        "amount": -7945,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_2",
        "description": "Depreciation for office leases",
        "amount": -2388,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_3",
        "description": "Other expense (gain on sale of assets to joint venture)",
        "amount": 28,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_4",
        "description": "Fair value adjustments",
        "amount": -972,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_5",
        "description": "Current income tax expense on other expense and fair value adjustments",
        "amount": -2009,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_6",
        "description": "FFO adjustments for joint ventures",
        "amount": 218,
        "source_page": "MD&A page 20, Table 25"
      },
      {
        "label": "other_7",
        "description": "Amortization of deferred financing costs",
        "amount": 1072,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      },
      {
        "label": "other_8",
        "description": "Accretion costs",
        "amount": 1128,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      },
      {
        "label": "other_9",
        "description": "Non-cash share-based compensation",
        "amount": 1970,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      },
      {
        "label": "other_10",
        "description": "Principal portion of government capital funding",
        "amount": 2037,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      },
      {
        "label": "other_11",
        "description": "Additional maintenance capex (actual spending beyond depreciation)",
        "amount": -1525,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      },
      {
        "label": "other_12",
        "description": "AFFO adjustments for joint ventures",
        "amount": -91,
        "source_page": "MD&A page 20, Table 25 - AFFO adjustment"
      }
    ],
    "total_adjustments_reported": 12213,
    "total_adjustments_extracted": 12213,
    "reconciliation_complete": true,
    "missing_amount": 0,
    "calculation_method": "actual",
    "reserve_methodology": "",
    "missing_adjustments": [],
    "affo_reconciliation_check": "Net income 25,362 + FFO adjustments 12,213 = FFO 37,575. FFO 37,575 + AFFO adjustments 4,591 = AFFO 42,166. Reconciliation complete."
  },
  "acfo_components": {
    "cash_flow_from_operations": 4244,
    "change_in_working_capital": 0,
    "interest_financing": 0,
    "jv_distributions": 0,
    "jv_acfo": 0,
    "jv_notional_interest": 0,
    "capex_sustaining_acfo": 0,
    "capex_development_acfo": 0,
    "leasing_costs_external": 0,
    "tenant_improvements_acfo": 0,
    "realized_investment_gains_losses": 0,
    "taxes_non_operating": 0,
    "transaction_costs_acquisitions": 0,
    "transaction_costs_disposals": 0,
    "deferred_financing_fees": 0,
    "debt_termination_costs": 0,
    "off_market_debt_favorable": 0,
    "off_market_debt_unfavorable": 0,
    "interest_income_timing": 0,
    "interest_expense_timing": 0,
    "puttable_instruments_distributions": 0,
    "rou_sublease_principal_received": 0,
    "rou_sublease_interest_received": 0,
    "rou_lease_principal_paid": 0,
    "rou_depreciation_amortization": 0,
    "non_controlling_interests_acfo": 0,
    "nci_puttable_units": 0,
    "calculation_method_acfo": "actual",
    "reserve_methodology_acfo": "",
    "jv_treatment_method": "distributions",
    "missing_adjustments_acfo": ["Issuer does not report ACFO - extraction not available. Phase 3 would need to calculate from CFO + adjustments if required."]
  },
  "cash_flow_investing": {
    "development_capex": 0,
    "property_acquisitions": 0,
    "property_dispositions": 0,
    "jv_capital_contributions": 0,
    "jv_return_of_capital": 0,
    "business_combinations": 0,
    "other_investing_outflows": -109192,
    "other_investing_inflows": 2037,
    "total_cfi": -107155,
    "note": "Detailed breakdown of investing activities not provided in cash flow statement. Total investing activities extracted from table on page 7 of financial statements: Purchase of property, equipment and intangible assets (109,192), Change in other assets 2,037. Extendicare properties are owner-occupied LTC homes, not investment properties, so traditional REIT categories don't apply."
  },
  "cash_flow_financing": {
    "debt_principal_repayments": 0,
    "new_debt_issuances": 0,
    "distributions_common": -30404,
    "distributions_preferred": 0,
    "distributions_nci": 0,
    "equity_issuances": 0,
    "unit_buybacks": 0,
    "deferred_financing_costs_paid": 0,
    "other_financing_outflows": 0,
    "other_financing_inflows": 0,
    "total_cff": 0,
    "note": "Detailed financing activities breakdown not fully disclosed in cash flow statement tables extracted. Distributions declared: $30,404 thousand (nine months ended Sep 30, 2023). Complete cash flow statement shows operating activities: $4,244 thousand."
  },
  "liquidity": {
    "cash_and_equivalents": 96252,
    "marketable_securities": 0,
    "restricted_cash": 599,
    "undrawn_credit_facilities": 75800,
    "credit_facility_limit": 112300,
    "available_cash": 95653,
    "total_available_liquidity": 171453,
    "data_source": "Balance sheet (cash: 96,252; restricted cash: 599), MD&A page 26 (credit facilities: $112.3M limit, $75.8M undrawn capacity). Credit facilities: one secured by 13 Class C LTC homes in Ontario, one secured by home health care business assets. As at Sep 30, 2023: $27.3M securing pension obligations, $3.0M for JV capital contributions, $6.2M for LTC home obligations = $36.5M drawn, leaving $75.8M undrawn."
  },
  "validation": {
    "balance_sheet_balanced": true,
    "noi_margin_reasonable": true,
    "balance_sheet_check": "Assets $687,994 = Liabilities $592,365 + Equity $95,629. Balances correctly.",
    "noi_margin_check": "Nine months NOI margin: 108,244 / 954,776 = 11.3%. Reasonable for healthcare services company.",
    "interest_coverage_check": "Trailing 12-month interest coverage ratio: 3.1x (per MD&A page 25). Adequate coverage.",
    "dilution_check": "Convertible debentures: face value $126.5M. Dilutive effect: 10,888 units (12.78% dilution). Material dilution if converted.",
    "ffo_affo_validation": "FFO payout ratio: $30,404 / $37,575 = 80.9%. AFFO payout ratio: $30,404 / $42,166 = 72.1%. Sustainable distribution levels."
  }
}
